There is no specific treatment for<unk><unk>  and treatment is supportive, with assistance given for feeding, breathing or seizure control as required. Raised intracranial pressure may be managed with mannitol. There is no transmission from person to person and therefore patients do not need to be isolated. A breakthrough in the field of<unk><unk>  therapeutics is the identification of macrophage receptor involvement in the disease severity. A recent report of an Indian group demonstrates the involvement of monocyte and macrophage receptor CLEC5A in severe inflammatory response in<unk><unk>  infection of the brain. This transcriptomic study provides a hypothesis of neuroinflammation and a new lead in development of appropriate therapies for<unk><unk> . The effectiveness of intravenous immunoglobulin for the management of<unk>  is unclear due to a lack of evidence. Intravenous immunoglobulin for<unk><unk>  appeared to have no benefit.
medical cause of Japanese encephalitis
symptom of Japanese encephalitis
symptom of Eastern equine encephalitis
symptom of West Nile fever
symptom of Rabies
symptom of Tuberculous meningitis
symptoms of Rabies
symptom of Neuroleptic malignant syndrome